Cargando…
Erratum to a right atrium metastasis of breast cancer after long-term endocrine therapy
Autores principales: | Xu, Fengrui, Wang, Xiaodi, Jiang, Zefei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7290635/ https://www.ncbi.nlm.nih.gov/pubmed/32566596 http://dx.doi.org/10.21037/atm-2020-22 |
Ejemplares similares
-
Erratum to prophylaxis of breast cancer chemotherapy for bone marrow toxicity: more individualized and safer
por: Xu, Fengrui, et al.
Publicado: (2020) -
Erratum to: Countless uninvited guests in left atrium
Publicado: (2021) -
Erratum to efficacy and safety of mecapegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in patients with breast cancer: a randomized, multicenter, active-controlled phase III trial
por: Xu, Fengrui, et al.
Publicado: (2020) -
Erratum to: Patient costs of breast cancer endocrine therapy agents under Medicare Part D vs with generic formulations
por: Nattinger, Ann Butler, et al.
Publicado: (2015) -
Erratum for
Multiple Endocrine Neoplasia Type 1 with Functional Parathyroid Cysts
por: Koyama, Nobuyuki, et al.
Publicado: (2022)